EMERGENT BIOSOLUTIONS INC. Comprehensive Income
EMERGENT BIOSOLUTIONS INC. (EBS) reported Comprehensive Income of -$180.10 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Income Statement › Unrealized Gains
us-gaap:ComprehensiveIncomeNetOfTax · last filed 2026-08-06
- EMERGENT BIOSOLUTIONS INC. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2026-06-30 was -$180.10M.
- EMERGENT BIOSOLUTIONS INC. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2026-03-31 was $7.40M, a 88.97% decline year-over-year.
- EMERGENT BIOSOLUTIONS INC. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2025-12-31 was -$54.60M.
- EMERGENT BIOSOLUTIONS INC. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2025-09-30 was $51.80M, a 54.16% decline year-over-year.
- EMERGENT BIOSOLUTIONS INC. comprehensive income (loss), net of tax, attributable to parent for fiscal 2025 was $50.30M.
- EMERGENT BIOSOLUTIONS INC. comprehensive income (loss), net of tax, attributable to parent for fiscal 2024 was -$190.10M.
- EMERGENT BIOSOLUTIONS INC. comprehensive income (loss), net of tax, attributable to parent for fiscal 2023 was -$769.30M.
- EMERGENT BIOSOLUTIONS INC. comprehensive income (loss), net of tax, attributable to parent for fiscal 2022 was -$192.40M, a 184.13% decline from fiscal 2021.
| Period end | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 3 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 3 month as first filed | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 6 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 6 month as first filed | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 9 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 9 month as first filed | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 12 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$180.10M 10-Q · filed 2026-08-06 | -$172.70M 10-Q · filed 2026-08-06 | -$227.30M derived: sum of 3 quarters · filed 2026-08-06 | -$175.50M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2026-03-31 | $7.40M 10-Q · filed 2026-05-01 | -$47.20M derived: sum of 2 quarters · filed 2026-05-01 | $4.60M derived: sum of 3 quarters · filed 2026-05-01 | -$9.40M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-12-31 | -$54.60M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | -$2.80M derived: sum of 2 quarters · filed 2026-02-27 | -$16.80M derived: sum of 3 quarters · filed 2026-08-06 | $50.30M 10-K · filed 2026-02-27 | ||||
| 2025-09-30 | $51.80M 10-Q · filed 2025-10-30 | $37.80M derived: sum of 2 quarters · filed 2026-08-06 | $104.90M 10-Q · filed 2025-10-30 | $75.70M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-06-30 | -$14.00M 10-Q · filed 2026-08-06 | $53.10M 10-Q · filed 2026-08-06 | $23.90M derived: sum of 3 quarters · filed 2026-08-06 | $136.90M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-03-31 | $67.10M 10-Q · filed 2026-05-01 | $37.90M derived: sum of 2 quarters · filed 2026-05-01 | $150.90M derived: sum of 3 quarters · filed 2026-05-01 | -$132.20M derived: sum of 4 quarters · filed 2026-05-01 | ||||
| 2024-12-31 | -$29.20M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $83.80M derived: sum of 2 quarters · filed 2026-02-27 | -$199.30M derived: sum of 3 quarters · filed 2026-02-27 | -$190.10M 10-K · filed 2026-02-27 | ||||
| 2024-09-30 | $113.00M 10-Q · filed 2025-10-30 | -$170.10M derived: sum of 2 quarters · filed 2025-10-30 | -$160.90M 10-Q · filed 2025-10-30 | -$213.50M derived: sum of 4 quarters · filed 2026-02-27 | ||||
| 2024-06-30 | -$283.10M 10-Q · filed 2025-08-07 | -$273.90M 10-Q · filed 2025-08-07 | -$326.50M derived: sum of 3 quarters · filed 2026-02-27 | -$590.90M derived: sum of 4 quarters · filed 2026-02-27 | ||||
| 2024-03-31 | $9.20M 10-Q · filed 2025-05-08 | -$43.40M derived: sum of 2 quarters · filed 2026-02-27 | -$307.80M derived: sum of 3 quarters · filed 2026-02-27 | -$571.80M derived: sum of 4 quarters · filed 2026-02-27 | ||||
| 2023-12-31 | -$52.60M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | -$317.00M derived: sum of 2 quarters · filed 2026-02-27 | -$581.00M derived: sum of 3 quarters · filed 2026-02-27 | -$769.30M 10-K · filed 2026-02-27 | ||||
| 2023-09-30 | -$264.40M 10-Q · filed 2024-11-07 | -$528.40M derived: sum of 2 quarters · filed 2024-11-07 | -$716.70M 10-Q · filed 2024-11-07 | -$775.40M derived: sum of 4 quarters · filed 2025-03-04 | ||||
| 2023-06-30 | -$264.00M 10-Q · filed 2024-08-07 | -$263.90M 10-Q · filed 2023-08-09 | -$452.30M 10-Q · filed 2024-08-07 | -$449.00M 10-Q · filed 2023-08-09 | -$511.00M derived: sum of 3 quarters · filed 2025-03-04 | -$597.20M derived: sum of 4 quarters · filed 2025-03-04 | ||
| 2023-03-31 | -$188.30M 10-Q · filed 2024-05-02 | -$185.10M 10-Q · filed 2023-05-10 | -$247.00M derived: sum of 2 quarters · filed 2025-03-04 | -$333.20M derived: sum of 3 quarters · filed 2025-03-04 | -$386.40M derived: sum of 4 quarters · filed 2025-03-04 | |||
| 2022-12-31 | -$58.70M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-04 | -$144.90M derived: sum of 2 quarters · filed 2025-03-04 | -$198.10M derived: sum of 3 quarters · filed 2025-03-04 | -$192.40M 10-K · filed 2025-03-04 | -$204.60M 10-K · filed 2023-03-01 | |||
| 2022-09-30 | -$86.20M 10-Q · filed 2023-12-11 | -$74.80M 10-Q · filed 2022-11-09 | -$139.40M derived: sum of 2 quarters · filed 2023-12-11 | -$133.70M 10-Q · filed 2023-12-11 | -$124.90M 10-Q · filed 2022-11-09 | $48.60M derived: sum of 4 quarters · filed 2024-03-08 | ||
| 2022-06-30 | -$53.20M 10-Q · filed 2023-08-09 | -$50.10M 10-Q · filed 2023-08-09 | $134.80M derived: sum of 3 quarters · filed 2024-03-08 | $101.40M derived: sum of 4 quarters · filed 2024-03-08 | ||||
| 2022-03-31 | $3.10M 10-Q · filed 2023-05-10 | $188.00M derived: sum of 2 quarters · filed 2024-03-08 | $154.60M derived: sum of 3 quarters · filed 2024-03-08 | $161.20M derived: sum of 4 quarters · filed 2024-03-08 | ||||
| 2021-12-31 | $184.90M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-08 | $151.50M derived: sum of 2 quarters · filed 2024-03-08 | $158.10M derived: sum of 3 quarters · filed 2024-03-08 | $228.70M 10-K · filed 2024-03-08 | $240.10M 10-K · filed 2022-02-25 | |||
| 2021-09-30 | -$33.40M 10-Q · filed 2022-11-09 | -$26.80M derived: sum of 2 quarters · filed 2022-11-09 | $43.80M 10-Q · filed 2022-11-09 | $225.60M derived: sum of 4 quarters · filed 2023-12-11 | ||||
| 2021-06-30 | $6.60M 10-Q · filed 2022-08-02 | $77.20M 10-Q · filed 2022-08-02 | $259.00M derived: sum of 3 quarters · filed 2023-12-11 | $299.30M derived: sum of 4 quarters · filed 2023-12-11 | ||||
| 2021-03-31 | $70.60M 10-Q · filed 2022-04-29 | $252.40M derived: sum of 2 quarters · filed 2023-12-11 | $292.70M derived: sum of 3 quarters · filed 2023-12-11 | $384.40M derived: sum of 4 quarters · filed 2023-12-11 | ||||
| 2020-12-31 | $181.80M derived: 10-K/A 12 month − 10-Q 9 month · filed 2023-12-11 | $222.10M derived: sum of 2 quarters · filed 2023-12-11 | $313.80M derived: sum of 3 quarters · filed 2023-12-11 | $290.00M 10-K/A · filed 2023-12-11 | $289.70M 10-K · filed 2021-02-19 | |||
| 2020-09-30 | $40.30M 10-Q · filed 2021-11-05 | $132.00M derived: sum of 2 quarters · filed 2021-11-05 | $108.20M 10-Q · filed 2021-11-05 | $154.30M derived: sum of 4 quarters · filed 2022-02-25 | ||||
| 2020-06-30 | $91.70M 10-Q · filed 2021-07-30 | $67.90M 10-Q · filed 2021-07-30 | $114.00M derived: sum of 3 quarters · filed 2022-02-25 | $153.10M derived: sum of 4 quarters · filed 2022-02-25 | ||||
| 2020-03-31 | -$23.80M 10-Q · filed 2021-04-30 | $22.30M derived: sum of 2 quarters · filed 2022-02-25 | $61.40M derived: sum of 3 quarters · filed 2022-02-25 | $51.40M derived: sum of 4 quarters · filed 2022-02-25 | ||||
| 2019-12-31 | $46.10M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-25 | $85.20M derived: sum of 2 quarters · filed 2022-02-25 | $75.20M derived: sum of 3 quarters · filed 2022-02-25 | $50.10M 10-K · filed 2022-02-25 | ||||
| 2019-09-30 | $39.10M 10-Q · filed 2020-11-06 | $29.10M derived: sum of 2 quarters · filed 2020-11-06 | $4.00M 10-Q · filed 2020-11-06 | -$200.00K derived: sum of 4 quarters · filed 2021-02-19 | ||||
| 2019-06-30 | -$10.00M 10-Q · filed 2020-07-31 | -$35.10M 10-Q · filed 2020-07-31 | -$39.30M derived: sum of 3 quarters · filed 2021-02-19 | -$18.60M derived: sum of 4 quarters · filed 2021-02-19 | ||||
| 2019-03-31 | -$25.00M 10-Q · filed 2020-05-01 | -$29.30M derived: sum of 2 quarters · filed 2021-02-19 | -$8.60M derived: sum of 3 quarters · filed 2021-02-19 | $40.30M derived: sum of 4 quarters · filed 2021-02-19 | ||||
| 2018-12-31 | -$4.30M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-19 | $16.40M derived: sum of 2 quarters · filed 2021-02-19 | $65.30M derived: sum of 3 quarters · filed 2021-02-19 | $60.90M 10-K · filed 2021-02-19 | ||||
| 2018-09-30 | $20.70M 10-Q · filed 2019-11-07 | $69.60M derived: sum of 2 quarters · filed 2019-11-07 | $65.20M 10-Q · filed 2019-11-07 | |||||
| 2018-06-30 | $48.90M 10-Q · filed 2019-08-02 | $44.50M 10-Q · filed 2019-08-02 | ||||||
| 2017-12-31 | $83.20M 10-K · filed 2020-02-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ENANTA PHARMACEUTICALS INC (ENTA) | United States | $0.349B | -6.72 |
| Larimar Therapeutics, Inc. (LRMR) | United States | $0.344B | -1.83 |
| Vogenx, Inc. (VOGX) | United States | $0.355B | |
| Benitec Biopharma Inc. (BNTC) | United States | $0.337B | -10.08 |
| BioAge Labs, Inc. (BIOA) | United States | $0.333B | -11.88 |
| BridgeBio Oncology Therapeutics, Inc. (BBOT) | United States | $0.320B | -3.35 |
| Evommune, Inc. (EVMN) | United States | $0.320B | -5.10 |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |
| ABEONA THERAPEUTICS INC. (ABEO) | United States | $0.312B | -5.63 |
| Rezolute, Inc. (RZLT) | United States | $0.382B | -6.45 |